Kiromic BioPharma Reports 32% Decrease in Tumor Volume Eight Months[...]
Alzamend Neuro Reports Second Quarter 2025 Financial Results and[...]
Krystal Biotech Announces Initial Clinical Update for Rare Respiratory[...]
12/12/2024 | Press release | Distributed by Public on 12/12/2024 07:00
Please select the service you want to use:
Smartlinks | InnovAge Holding Corporation | News | Health | Healthcare Service Providers | Hospitals and Healthcare Facilities | Healthcare Policy | Healthcare Equipment and Services | Politics and Policy | Healthcare Policy | Government | National Government | Company News | Business Announcement | Financial Services | Insurance | Securities Issuers | Healthcare Providers and Services Companies | NYSE American | NYSE ARCA Equities | Nasdaq Global Select Market | Cboe BZX Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | NYSE National | FINRA Alternative Display Facility (ADF) | Nasdaq BX | Nasdaq PSX | NYSE Chicago
Back
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact